No levothyroxine, since it is contraindicated in cardiac disease

A patient with type 2 diabetes and established coronary artery disease has an A1C of 6.9%, already near target on metformin alone. Based on comorbidity-driven treatment principles, should additional therapy be considered?

What are the three primary lipid parameters of clinical concern, and how are LDL-C and HDL-C commonly remembered?

How does the AHA staging system differ from the NYHA classification system for heart failure?

A 65-year-old patient with type 2 diabetes and no history of bleeding disorders asks about starting daily aspirin for primary cardiovascular prevention. What is the most appropriate guidance?

An elderly patient with multiple comorbidities presents with pneumonia symptoms, fever, and an elevated white blood cell count. Integrating the age-specific microbiology considerations, treatment protocols, and hospitalization criteria, what is the most comprehensive approach?

A 45-year-old patient with a smoking history, above-average alcohol intake, sedentary lifestyle, and no prior HPV vaccination presents for a wellness visit. Integrating the primary prevention counseling framework across multiple modifiable risk factors, what is the most complete evidence-based approach for this single visit?

A patient started on statin therapy three weeks ago now reports new, unexplained muscle pain. What is the most appropriate next step?

A pregnant patient in her first trimester is newly diagnosed with hyperthyroidism requiring antithyroid drug therapy. Which medication should be selected, and why?

A patient with mild cognitive impairment has confirmed amyloid pathology on PET imaging. Is this patient a candidate for anti-amyloid monoclonal antibody therapy such as Leqembi or Kisunla?